Medications for Menopause Symptoms
For menopausal symptoms, first-line treatment should include nonhormonal options such as SNRIs, SSRIs, gabapentin, and lifestyle modifications, with hormonal therapy reserved for those without contraindications who have persistent symptoms. 1
Vasomotor Symptoms (Hot Flashes/Night Sweats)
Nonhormonal Pharmacologic Options (First-Line)
SNRIs/SSRIs:
Anticonvulsants:
Other medications:
- Clonidine (antihypertensive): Used clinically for hot flashes 1
Hormonal Options (Second-Line)
Vaginal/Urogenital Symptoms
Nonhormonal Options (First-Line)
Vaginal moisturizers and lubricants:
Ospemifene: FDA-approved nonhormonal treatment for dyspareunia due to menopausal atrophy 4
Hormonal Options (Second-Line)
- Local estrogen therapy:
Special Considerations
Breast Cancer Survivors
Complementary Approaches
Lifestyle modifications:
Other therapies with some evidence:
Treatment Algorithm
- Assess symptom severity and impact on quality of life
- Rule out other medical causes (thyroid disease, diabetes) 1
- For vasomotor symptoms:
- Start with nonhormonal options (SNRIs/SSRIs, gabapentin) and lifestyle modifications
- If inadequate relief and no contraindications, consider hormone therapy
- For vaginal symptoms:
- Start with nonhormonal moisturizers and lubricants
- If inadequate relief, consider local vaginal estrogen (if no contraindications)
Common Pitfalls to Avoid
- Using systemic hormone therapy in women with history of breast cancer 1, 5
- Prescribing estrogen alone in women with intact uterus (increases endometrial cancer risk) 1
- Using paroxetine in women taking tamoxifen (may reduce tamoxifen efficacy) 1
- Continuing hormone therapy longer than necessary (increased breast cancer risk with combined therapy used >3-5 years) 4
- Overlooking nonpharmacological approaches that may provide significant relief 1
Remember that menopausal symptoms can persist for more than a decade, with genitourinary symptoms typically being progressive 6. Timely and appropriate treatment can significantly improve quality of life during this transition.